The Prolonged Use of Topiramate for Preventing Migraine Headaches
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness (beyond 6 months) of
individualized doses (100 to 200 milligrams) of topiramate for the prevention of migraine
headaches over a period of 26 weeks.